3-73062268-G-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_018029.4(EBLN2):c.187G>T(p.Asp63Tyr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000138 in 1,450,776 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_018029.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
EBLN2 | NM_018029.4 | c.187G>T | p.Asp63Tyr | missense_variant | 1/1 | ENST00000533473.1 | NP_060499.3 | |
PPP4R2 | NM_174907.4 | c.419+1208G>T | intron_variant | ENST00000356692.10 | NP_777567.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
EBLN2 | ENST00000533473.1 | c.187G>T | p.Asp63Tyr | missense_variant | 1/1 | 6 | NM_018029.4 | ENSP00000432104.1 | ||
PPP4R2 | ENST00000356692.10 | c.419+1208G>T | intron_variant | 1 | NM_174907.4 | ENSP00000349124.5 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 0.00000138 AC: 2AN: 1450776Hom.: 0 Cov.: 63 AF XY: 0.00000277 AC XY: 2AN XY: 721558
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 06, 2021 | The c.187G>T (p.D63Y) alteration is located in exon 1 (coding exon 1) of the EBLN2 gene. This alteration results from a G to T substitution at nucleotide position 187, causing the aspartic acid (D) at amino acid position 63 to be replaced by a tyrosine (Y). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.